What you need to do: Drink electrolytes first: this will help alleviate any legacy symptoms you may be experiencing, such as headache or fatigue
While this specific combination hasn't been studied in controlled trials, BPC-157's documented gastroprotective and anti-ulcer effects in animal models provide a mechanistic rationale for its use alongside medications that can irritate the GI tract
Preliminary data suggest cotadutide has beneficial effects comparable to GLP-1 receptor agonists, including reductions in urinary albumin-to-creatinine ratio, even in patients with an estimated glomerular filtration rate (eGFR) as low as 20 mL/min/1.73 m
10.4254/wjh.v5.i9.470 23 LheureuxP
The mechanism of action isnt well understood, but its believed it doesnt affect the tendon tissue cells directly, but rather that either works by activating other repair cells that can help tendons or ligaments or making the human growth factor receptor on the repair cells more sensitive (3)
Many of the cardiovascular and metabolic trials informing the discussion were not designed to evaluate ophthalmic outcomes. The authors called for prospective ophthalmology-specific studies incorporating imaging biomarkers, visual outcomes and disease-specific monitoring, noting that parsing the protective benefits or adverse effects of this rapidly growing medication class will be essential to refining disease management and improve patient outcomes. As GLP-1 therapies become increasingly common among patients with diabetes, obesity and vascular comorbiditiesprecisely the populations populating ophthalmic clinicsthe field may not have the luxury of waiting for cleaner data